Pluri Inc.
PLUR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001158780
No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Pluri Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 19 | 15 | −4 |
| Shares | 52.3K | 26.3K | −26.0K (−49.8%) |
| Value | $234.9K | $78.2K | −$156.7K (−66.7%) |
New holders (1)
Institutions that held Pluri Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 20 | $60 | 0.00% |
Sold out (5)
Institutions that held Pluri Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Values First Advisors, Inc. | 11,907 | $53.3K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 136 | $651 |
| Quent Capital, LLC | 57 | $255 |
| Huntington National Bank | 38 | $170 |
| IFP Advisors, Inc | 1 | $4 |